These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9216707

  • 1. Serum tissue polypeptide specific antigen (TPS) in patients with cervical carcinoma: preliminary report.
    Pattaranutaporn P, Chansilpa Y, Tangkarat S, Tepmongkol P, Sangruchi S, Senapad S.
    Anticancer Res; 1997; 17(3C):2309-12. PubMed ID: 9216707
    [Abstract] [Full Text] [Related]

  • 2. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC, Shiau YC, Chang WC, Kao CH, Lin CC.
    Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
    [Abstract] [Full Text] [Related]

  • 3. Serum tissue polypeptide specific antigen (TPS) in locoregional failure and distant metastasis of cervical carcinoma.
    Pattaranutaporn P, Chansilpa Y, Ieumwananonthachai N, Sukkasem M.
    J Med Assoc Thai; 2000 Sep; 83(9):1011-5. PubMed ID: 11075966
    [Abstract] [Full Text] [Related]

  • 4. Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma.
    Tai CJ, Liu FY, Liang JA, Yang SN, Tsai MH, Kao CH.
    Anticancer Res; 2002 Sep; 22(6B):3793-6. PubMed ID: 12552995
    [Abstract] [Full Text] [Related]

  • 5. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer.
    Gitsch G, Kainz C, Joura E, Fröhlich B, Bieglmayr C, Tatra G.
    Anticancer Res; 1992 Sep; 12(4):1247-9. PubMed ID: 1503417
    [Abstract] [Full Text] [Related]

  • 6. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer.
    Sliutz G, Tempfer C, Kainz C, Mustafa G, Gitsch G, Koelbl H, Biegelmayer C.
    Anticancer Res; 1995 Sep; 15(3):1127-9. PubMed ID: 7645936
    [Abstract] [Full Text] [Related]

  • 7. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
    Sun SS, Hsieh JF, Tsai SC, Ho YJ, Kao CH.
    Anticancer Res; 2000 Sep; 20(6C):4661-3. PubMed ID: 11205197
    [Abstract] [Full Text] [Related]

  • 8. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB.
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [Abstract] [Full Text] [Related]

  • 9. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy.
    Padungsutt P, Thirapagawong C, Senapad S, Suphanit I.
    Anticancer Res; 2000 Apr; 20(2B):1291-5. PubMed ID: 10810437
    [Abstract] [Full Text] [Related]

  • 10. Comparison of pre-treatment CYFRA 21 - 1 and SCC-Antigen assay in primary cervical carcinoma - a preliminary report.
    Puthucode-Easwaran S, Naik R, Athavale R, Handley G, Lopes A, Godfrey K, Hatem M.
    J Obstet Gynaecol; 2005 Jul; 25(5):486-8. PubMed ID: 16183586
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
    van Dalen A, Favier J, Baumgartner L, Hasholzner U, de Bruijn H, Dobbler D, Dombi VH, Fink D, Giai M, McGing P, Harlozinska A, Kainz C, Markowska J, Molina R, Sturgeon C, Einarsson R.
    Anticancer Res; 1999 Jul; 19(4A):2523-6. PubMed ID: 10470187
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic value of tissue-polypeptide specific antigen (TPS) in bladder cancer.
    Menendez V, Galan JA, Fernandez-Suarez A, Lopez S, Alcover J, Calpena R, Filella X.
    Anticancer Res; 2002 Jul; 22(6B):3713-6. PubMed ID: 12552981
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance of RCAS1 as a biomarker of uterine cancer.
    Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H.
    Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic value of combined serum biomarkers in predicting outcomes in cervical cancer patients.
    Li J, Cheng H, Zhang P, Dong Z, Tong HL, Han JD, Guo F, Tian YP.
    Clin Chim Acta; 2013 Sep 23; 424():292-7. PubMed ID: 23850705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.